Ocular Therapeutix Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Ocular Therapeutix stock has a consensus rating of "Strong Buy" and an average price target of $26. The average 1-year stock price forecast is 209.89% higher than the current stock price, while the lowest is $18 (+114.54%) and the highest is $34 (+305.24%).

Price Target: $26 (+209.89%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$18	$26	$27	$34
Change	+114.54%	+209.89%	+221.81%	+305.24%

* Price targets were last updated on May 6, 2026.

Analyst Ratings

The average analyst rating for Ocular Therapeutix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	8	8	8	7	7	7
Buy	4	4	4	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	12	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Daniil Gataulin Chardan Capital	Chardan Capital	Buy Reiterates $21	Buy	Reiterates	$21	+150.30%	May 6, 2026
Lisa Walter RBC Capital	RBC Capital	Buy Maintains $30	Buy	Maintains	$30	+257.57%	May 6, 2026
Yi Chen H.C. Wainwright	H.C. Wainwright	Buy Reiterates $21	Buy	Reiterates	$21	+150.30%	May 6, 2026
Serge Belanger Needham	Needham	Buy Maintains $18	Buy	Maintains	$18	+114.54%	May 5, 2026
Tara Bancroft TD Cowen	TD Cowen	Buy Maintains $20	Buy	Maintains	$20	+138.38%	May 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

51.87M

from 51.95M

-0.16%

from 51.95M

Revenue Next Year

116.16M

from 51.87M

123.95%

from 51.87M

EPS This Year

-1.62

from -1.42

EPS Next Year

-1.60

from -1.62

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	43.52M	51.49M	58.44M	63.72M	51.95M	51.87M
Revenue Growth	150.08%	18.32%	13.50%	9.03%	-18.47%	-0.16%
Gross Profit	-10.97M	-6.51M	-7.89M	-69.54M	-151.72M	46.33M
Gross Margin	-25.20%	-12.64%	-13.51%	-109.13%	-292.04%	89.33%
Operating Income	-78.04M	-78.65M	-82.38M	-160.88M	-270.02M	-373.88M
Net Income	-6.55M	-71.04M	-80.74M	-193.51M	-265.94M	-361.51M
EPS	-	-	-	-	-1.42	-1.62
Free Cash Flow	-38.07M	-33.30M	-49.44M	-79.78M	-128.28M	-279.00M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	56.3M
Avg	51.9M
Low	45.4M

Revenue Growth

Revenue Growth	2026	2027	2028
High	8.4%
Avg	-0.2%
Low	-12.6%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-1.62
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-